Welcome to BioReagent Hub Hotline:19920083827
本站自营/精选产品 www.yeasen.com  |  价格与库存以本站实时信息为准
本站精选 · 品质自营查看原始页面 ›
Vendor Tel:400-6111-883
Product data sheet PD-93860ES
Recombinant Human SLAMF6/NTB-A Protein,His-Avi Tag Recombinant Human SLAMF6/NTB-A Protein,His-Avi Tag
Enquiry

Tell us your volume and application; we reply with a quote.

Start enquiry

Recombinant Human SLAMF6/NTB-A Protein,His-Avi Tag

Scan for product
HEK293细胞表达系统抗体药物靶点研究
Product no.93860ES Sizes3 options SourceYeasen · Official
Cat. No. 93860ES60
现货 $3,585.00
Qty 1
Enquire now
Enquire / bulk Compare

Specifications & Enquiry

Tick the specs you need to submit them together; or enquire one by one. Cat. numbers are carried into the RFQ.

Cat.No Spec Price Status
93860ES60 100 μg $3,585.00 现货 Enquire
93860ES76 500 μg $12,355.00 现货 Enquire
93860ES25 25 μg $1,195.00 现货 Enquire
Submit enquiry Price is on application; bulk sizes can be sampled on request.

Overview

Specifications

Brand翌圣生物 Yeasen
Cat.No93860ES
Specification高纯度、高活性、低内毒素、高批间一致性
Origin翌圣生物科技(上海)股份有限公司
技术平台 HEK293细胞表达系统
应用方法 抗体药物靶点研究作为靶点蛋白用于抗体药物筛选与功能研究
适用物种种属 人
检测方法 ELISA SDS-PAGE HPLC LAL法
生物特性参数 蛋白类型重组蛋白/靶点蛋白/抗体药物靶点蛋白 种属来源人 生物活性描述ELISA法检测:0.5 μg/ml Human SLAMF6 His Tag包板,Anti-SLAMF6 Antibody hFc Tag剂量反应曲线EC50为7.9 ng/ml。 应用抗体药物靶点研究 蛋白登录号Q96DU3-1
样本类型 重组蛋白
技术参数 纯度> 95% as determined by SDS-PAGE and HPLC. 内毒素水平< 1.0 EU per μg by the LAL method. 分子量Predicted MW 26 kDa; due to glycosylation migrates to 35-50 kDa by SDS-PAGE. 制剂形式Lyophilized from 0.22μm filtered solution in PBS (pH 7.4); normally 8% trehalose added as protectant before lyophilization. 活性EC50 of 7.9 ng/ml determined by ELISA for Anti-SLAMF6 Antibody hFc Tag binding to immobilized Human SLAMF6 His Tag. 储存条件-25 ~ -15℃保存,有效期1年;复溶后,无菌条件下-85 ~ -65℃保存,有效期3个月。 表达序列Gln22-Met226 表达系统HEK293 标签C-His-Avi 外观Lyophilized Powder 复溶方法开盖前先离心;使用蒸馏水复溶冻干蛋白,复溶浓度超过100 μg/mL;建议分装避免反复冻融。 复溶浓度超过100 μg/mL 产品别称CD352 NTB-A ANK-T-B-antigen KALI
实验类型 ELISA生物活性/结合活性测定 SDS-PAGE纯度检测 HPLC纯度检测 LAL法内毒素检测

Recommended reading

Related products

✉Email 💬Message 👤Member
↑Top